fig6
![Unraveling the tau puzzle: a review of mechanistic targets and therapeutic interventions to prevent tau pathology in Alzheimer's disease](https://image.oaes.cc/48be6d03-d7e6-492c-8b63-9c49991c8e0a/and3020.fig.6.jpg)
Figure 6. Therapeutic modulators of tau propagation through intercellular organelle systems. (A) Myosin-10 blockers inhibit nanotube formation to inhibit intercellular propagation of pathologic tau[48-51]; (B) nSMase2 silencing and delivery of GW4869 inhibit exosome formation to prevent the exosomal release of tau[52]. Created with BioRender.com.